Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Duloxetine for the Treatment of Dysthymia.

Next Previous
Trial Profile

Duloxetine for the Treatment of Dysthymia.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Apr 2009

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Dysthymic disorder
  • Focus Therapeutic Use

Most Recent Events

  • 14 Apr 2009 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
  • 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 01 Apr 2009 Planned end date changed from 1 Apr 2006 to 1 Dec 2006 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top